Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
133 participants
INTERVENTIONAL
2015-05-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: One hundred-forty patients who will be scheduled for elective thoracic procedures using the DLT for one-lung ventilation will be randomly assigned to one of four groups (n=35 per group) to intubate using the MAC, GVL, Airtraq®, or KVL. Time to DLT intubation, glottis view, ease of intubation, number of optimization maneuvers, and failure to intubation (\>150 s.) will be recorded.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Videolaryngoscopes for Double Lumen Tube Intubations in Simulated Easy and Difficult Airway
NCT02640196
Comparison of the Macintosh, King Vision®, Glidescope® and AirTraq® Laryngoscopes in Routine Airway Management
NCT01914523
Macintosh Versus GlideScope Versus C-MAC for Double Lumen Endotracheal Intubation
NCT05091281
Comparison of the Glidescope and Macintosh Laryngoscope for Double Lumen Endotracheal Tube Intubation
NCT01404780
Nasal Intubation Using King Vision Video Laryngoscopy
NCT03126344
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are numerous VLs, including, stylets, channeled and traditional VLs. The GlideScope®-assisted DLT insertion (Verathon Inc., Bothell, WA, USA), has been associated with variable intubation durations according to the experience of the intubating operators, despite superior vocal cord views.\[6-7\] The channeled VL, like as the Airtraq® (Prodol Limited, Viscaya, Spain) and the standard non-channeled blade of the King Vision™ (KVL™) (King Systems, Indianapolis, IN, USA), may offer additional benefits for DLT intubation in patients with limited mouth opening or restricted neck movement, \[8-10\] in whom the use of traditional VL like as the Glidescope® could be difficult. This is because of the larger outer diameter, the distal curvature and the increased rigidity of the DLT.\[11\]
Of note, the longer intubation durations with the use of different VL-assisted DLT insertion could be shortened with building up the operator's experience.
Comparing the effects of the three studied VLs on the time to DLT intubation in humans has not yet been studied.
We hypothesize that time to successful DLT intubation using the channeled VL, namely, the Airtraq® and KVL™, will be shorter than with the Macintosh (MAC) laryngoscope and GlideScope® VL when used by non-expert anesthesiologists. We will compare the effects of the MAC, GlideScope®, Airtraq® and KVL™ on the time to DLT intubation, laryngoscopic view, ease of intubation, number of intubation attempts, and number of optimization maneuvers in patients undergoing thoracic procedures using DLTs for one-lung ventilation (OLV).
Standard monitoring, and bispectral index (BIS), or state and response entropy based depth of anesthesia, (GE Healthcare, Helsinki, Finland) will be applied to all patients. Neuromuscular blockade will be measured with a train of four stimulation (TOF) of the ulnar nerve. Invasive blood pressure monitoring will be achieved by cannulation of the radial artery. After preoxygenation, general anesthesia will be induced with propofol 1.5 to 3mg kg-1 and fentanyl 2-3 µg kg-1 or remifentanil 0.05-0.2 ug Kg-1 min-1, titrated to achieve a BIS value \< 60 or a state entropy values of less than 50 and a difference between response and state entropy of less than 10. Rocuronium (0.6 mg kg-1) will be given to facilitate intubation with an appropriate sized left-sided DLT.
In all groups, during the insertion of the DLT, exercise caution to avoid damage to the tracheal cuff by the upper teeth during its passage through the mouth opening. After DLT intubation, the tracheal cuff will be inflated and ventilation of the lungs commenced. Then, the correct position of its tip will be confirmed with a fiberoptic bronchoscope.
The first intubation attempt will be considered a failure if the trachea is not successfully intubated within 150 s or if the peripheral oxygen saturation (SpO2) decreases by 5%. Following an initial tracheal intubation failure, the participants will be allowed to use any maneuver and device they would normally use to navigate the DLT into the trachea.
Demographic data will be recorded including grade, experience with the VLs, and previous DLT intubation experience with the VLs.
All data, with the exception of the difficulty of device use score, will be recorded by blinded investigators.
A pilot study showed that the mean time to DLT intubation using the GlideScope® VL was 72 seconds with a standard deviation of 45.2 seconds. An a priori power analysis indicated that a sample size of 32 participants was sufficiently large to detect a 50% difference in the time to DLT intubation, during the use of the channeled VL, a type-I error of 0.008 (0.05/6 possible comparisons) and a power of 90%. We will add more patients (10%) for a final sample size of 35 participants to compensate dropping out during the study.
Data will be tested for normality using Kolmogorov-Smirnov test. Categorical data will be analyzed using the Fisher's exact test. Repeated-measures analysis of variance (ANOVA) will be used for continuous parametric variables, and the differences will be corrected by the post hoc Bonferroni test. Kruskal-Wallis test will be used for nonparametric values, and post hoc pairwise comparisons will be performed using the Wilcoxon rank-sum t test Continuous data will be presented as mean (standard deviation, SD), ordinal data will be presented as median (inter-quartile range), and categorical data will be presented as number (%). A value of p\< 0.05 will be considered to be statistically significant.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Macintosh
Double lumen tube intubation using Macintosh laryngoscope
Macintosh
double lumen tube intubation using the Macintosh laryngoscope
Glidescope®
Double lumen tube intubation using Glidescope® videolaryngoscope
Glidescope®
double lumen tube intubation using the Glidescope® videolaryngoscope. The distal portion of a left-sided DLT will be angulated to the right concealing the distal orifice of the tracheal lumen. The DLT will be advanced directly through the vocal cords after initial 90° clockwise rotation, the stylet will be removed, and then the DLT will be advanced gently while rotating in a 180° couterclockwise direction
Airtraq®
Double lumen tube intubation using Airtraq® videolaryngoscope
Airtraq®
double lumen tube intubation using the Airtraq® videolaryngoscope.
King Vision™
Double lumen tube intubation using King Vision™ videolaryngoscope
King Vision™
double lumen tube intubation using the King Vision™ videolaryngoscope. the distal 21 cm of the left-sided DLT will be bended to replicate the curve of the non-channeled blade and the proximal curve of the DLT remains directed to the right side. Then, after initial 90° clockwise rotation, the bronchial cuff passes through the vocal cords, the stylet of the DLT will be withdrawn and the DLT will be rotated 180°counterclockwise while advancing the DLT to the desired depth.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Macintosh
double lumen tube intubation using the Macintosh laryngoscope
Glidescope®
double lumen tube intubation using the Glidescope® videolaryngoscope. The distal portion of a left-sided DLT will be angulated to the right concealing the distal orifice of the tracheal lumen. The DLT will be advanced directly through the vocal cords after initial 90° clockwise rotation, the stylet will be removed, and then the DLT will be advanced gently while rotating in a 180° couterclockwise direction
Airtraq®
double lumen tube intubation using the Airtraq® videolaryngoscope.
King Vision™
double lumen tube intubation using the King Vision™ videolaryngoscope. the distal 21 cm of the left-sided DLT will be bended to replicate the curve of the non-channeled blade and the proximal curve of the DLT remains directed to the right side. Then, after initial 90° clockwise rotation, the bronchial cuff passes through the vocal cords, the stylet of the DLT will be withdrawn and the DLT will be rotated 180°counterclockwise while advancing the DLT to the desired depth.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective thoracic procedures
Exclusion Criteria
* forced expiratory volume in 1 s (FEV1) less than 50% of predicted values
* forced vital capacity (FVC) less than 50% of predicted values
* severe asthma
* pregnancy
* risk of regurgitation
* risk of pulmonary aspiration
* history of gastro-esophageal reflux
* body mass index more than 40 kg m-2
* anticipated difficult intubation
* preoperative postoperative ventilatory support
* planned postoperative ventilatory support
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imam Abdulrahman Bin Faisal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed R El Tahan, MD
Role: PRINCIPAL_INVESTIGATOR
Associate Professor at Anesthesiology Dept
Alaa khidr, MD
Role: STUDY_DIRECTOR
Imam Abdulrahman Bin Faisal University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
King Fahd Hospital of the University
Khobar, Eastern Province, Saudi Arabia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ANE-2014-11-27
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.